Barriers and facilitators to the inclusion of deaf people in clinical trials
Anderson, Melissa L
UMass Chan AffiliationsImplementation Science and Practice Advances Research Center (iSPARC)
Document TypeJournal Article
MetadataShow full item record
AbstractBackground/aims: This article discusses the barriers that prevent deaf people from participating in clinical trials and offers recommendations to overcome these barriers and ensure equal access to study participation. Methods: Between April and May 2022, we conducted six focus groups with 20 deaf adults who use American Sign Language, all of whom had previous experience as research study participants. Focus group prompts queried community awareness of clinical trial opportunities, barriers and facilitators to deaf people's participation in clinical trials, and recommended resources to improve clinical trial access. This qualitative focus group data is supplemented by survey data gathered from 40 principal investigators and clinical research coordinators between November 2021 and December 2021. The survey queried researchers' prior experiences with enrolling deaf participants in clinical trials and strategies they endorse for enrollment of deaf participants in future clinical trials. Results: Focus group participants unanimously agreed that, compared to the general hearing population, deaf sign language users lack equivalent access to clinical trial participation. Reported barriers included lack of awareness of clinical trial opportunities, mistrust of hearing researchers, and refusal by clinical trial staff to provide accessible communication (e.g. denial of requests for sign language interpreters). Survey data from 40 principal investigators and clinical research coordinators corroborated these barriers. For example, only 2 out of 40 survey respondents had ever enrolled a deaf person in a clinical trial. Respondents indicated that the most helpful strategies for including deaf sign language users in future clinical trials would be assistance with making recruitment information accessible to deaf sign language users and assistance in identifying qualified interpreters to hire to help facilitate the informed consent process. Conclusion: The lack of communication accessibility is the most common factor preventing deaf sign language users from participating in clinical trials. This article provides recommendations for hearing researchers to improve deaf people's access to clinical trials moving forward, drawing from mixed-methods data.
SourceKushalnagar P, Nicolarakis O, Mirus G, Anderson M, Burke T, Kushalnagar R. Barriers and facilitators to the inclusion of deaf people in clinical trials. Clin Trials. 2023 Oct;20(5):576-580. doi: 10.1177/17407745231177376. Epub 2023 May 26. PMID: 37243366; PMCID: PMC10524313.
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/52638